Direct-to-Consumer Advertising of Prescription Drugs and the Patient–Prescriber Encounter: A Systematic Review

References

• Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs–summary of FDA survey research results. Washington, DC: Food and Drug Administration. Center for Drug Evaluation and Research. Retrieved from. http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/ucm152860.pdf
   Google Scholar
• Allison-Ottey, S. D., Ruffin, K., Allison, K., & Ottey, C. C. (2003). Assessing the impact of direct-to-consumer advertisements on the AA patient: A multisite survey of patients during the office visit. Journal of the National Medical Association, 95(2), 120–131.
   PubMed Web of Science ®Google Scholar
• Allison-Ottey, S. D., Ruffin, K., & Allison, K. B. (2002). “To do no harm” survey of NMA physicians regarding perceptions on DTC advertisements. Journal of the National Medical Association, 94(4), 194–202.
   PubMed Web of Science ®Google Scholar
• Almasi, E. A., Stafford, R. S., Kravitz, R. L., & Mansfield, P. R. (2006). What are the public health effects of direct-to-consumer drug advertising?. PLoS Medicine, 3(3), e145. doi:10.1371/journal.pmed.0030145
   PubMed Web of Science ®Google Scholar
• American College of Physicians. (2006). Direct-to-consumer prescription drug advertising. Position paper. Philadelphia, PA: Author.
   Google Scholar
• Avorn, J., Chen, M., & Hartley, R. (1982). Scientific versus commercial sources of influence on the prescribing behavior of physicians. American Journal of Medicine, 73(1), 4–8.
   PubMed Web of Science ®Google Scholar
• Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14(11), 651–657.
   PubMed Web of Science ®Google Scholar
• Bell, R. A., Taylor, L. D., & Kravitz, R. L. (2010). Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians? Patient Education and Counseling, 81(2), 245–250. doi:10.1016/j.pec.2010.01.014
   PubMed Web of Science ®Google Scholar
• Bhanji, N. H., Baron, D. A., Lacy, B. W., Gross, L. S., Goin, M. K., Sumner, C. R., … Slaby, A. E. (2008). Direct-to-consumer marketing: An attitude survey of psychiatric physicians. Primary Psychiatry, 15(11), 67–71.
   Google Scholar
• Brodie, M. (2001). Understanding the effects of direct-to-consumer prescription drug advertising. Menlo Park, CA: Henry J Kaiser Family Foundation. Retrieved from http://www.kff.org/rxdrugs/loader.cfm?url9=/commonspot/security/getfile.cfm&PageID=13876.
   Google Scholar
• Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Williams, M. V., & Parker, R. M. (2004). Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9(6), 491–497. doi:10.1080/10810730490523115
   PubMed Web of Science ®Google Scholar
• DeLorme, D. E., Huh, J., & Reid, L. N. (2006). Age differences in how consumers behave following exposure to DTC advertising. Health Communication, 20(3), 255–265. doi:10.1207/s15327027hc2003_5
   PubMed Web of Science ®Google Scholar
• Dens, N., Eagle, L. C., & De Pelsmacker, P. (2008). Attitudes and self-reported behavior of patients, doctors, and pharmacists in New Zealand and Belgium toward direct-to-consumer advertising of medication. Health Communication, 23(1), 45–61. doi:10.1080/10410230701805190
   PubMed Web of Science ®Google Scholar
• Deshpande, A., Menon, A., Perri, M., III, & Zinkhan, G. (2004). Direct-to-consumer advertising and its utility in health care decision making: A consumer perspective. Journal of Health Communication, 9(6), 499–513. doi:10.1080/10810730490523197
   PubMed Web of Science ®Google Scholar
• Dieringer, N. J., Kukkamma, L., Somes, G. W., & Shorr, R. I. (2011). Self-reported responsiveness to direct-to-consumer drug advertising and medication use: Results of a national survey. BMC Health Services Research, 11(1), 232. doi:10.1186/1472-6963-11-232
   PubMedGoogle Scholar
• Duckwitz, N., & Yuan, Y. (2002). Doctors & DTC. Retrieved from http://www.pharmexec.com/print/243373?page=full.doi: 10.1044/1059-0889(2002/er01)
   Google Scholar
• Food, U. S., & Administration, D. (2015). Office of Prescription Drug Promotion (OPDP) research. Retrieved from http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm090276.htm
   Google Scholar
• Fortuna, R. J., Ross-Degnan, D., Finkelstein, J., Zhang, F., Campion, F. X., & Simon, S. R. (2008). Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice. Journal of Evaluation in Clinical Practice, 14(6), 969–973. doi:10.1111/j.1365-2753.2007.00913.x
   PubMed Web of Science ®Google Scholar
• Gellad, Z. F., & Lyles, K. W. (2007). Direct-to-consumer advertising of pharmaceuticals. American Journal of Medicine, 120(6), 475–480. doi:10.1016/j.amjmed.2006.09.030
   PubMed Web of Science ®Google Scholar
• Gilbody, S., Wilson, P., & Watt, I. (2005). Benefits and harms of direct to consumer advertising: A systematic review. Quality & Safety in Health Care, 14(4), 246–250. doi:10.1136/qshc.2004.012781
   PubMedGoogle Scholar
• Green, C. E., Mojtabai, R., Cullen, B. A., Spivak, A., Mitchell, M., & Spivak, S. (2017). Exposure to direct-to-consumer pharmaceutical advertising and medication nonadherence among patients with serious mental illness. Psychiatric Services, 68(12), 1299–1302. doi:10.1176/appi.ps.201700035
   PubMed Web of Science ®Google Scholar
• Herzenstein, M., Misra, S., & Posavac, S. S. (2004). How consumers’ attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Marketing Letters, 15(4), 201–212. doi:10.1007/s11002-005-0458-x
   Web of Science ®Google Scholar
• Hoek, J., & Maubach, N. (2007). Consumers’ knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines. New Zealand Medical Journal, 120(1249), U2425.
   PubMedGoogle Scholar
• Hornik, R., & Yanovitzky, I. (2003). Using theory to design evaluations of communication campaigns: The case of the national youth anti-drug media campaign. Communication Theory, 13(2), 204–224. doi:10.1111/j.1468-2885.2003.tb00289.x
   PubMed Web of Science ®Google Scholar
• Huh, J., DeLorme, D. E., & Reid, L. N. (2005). Factors affecting trust in on-line prescription drug information and impact of trust on behavior following exposure to DTC advertising. Journal of Health Communication, 10(8), 711–731. doi:10.1080/10810730500326716
   PubMed Web of Science ®Google Scholar
• Kelly, B., McFarlane, E. G., Southwell, B. G., Boudewyns, V., Chowdhury, D., Cullen, K., … Wohlgenant, K. (2013). Healthcare professional survey of prescription drug promotion: Methods report. Research Triangle Park, NC: RTI International.
   Google Scholar
• Khanfar, N. M., Polen, H. H., & Clauson, K. A. (2009). Influence on consumer behavior: The impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder. Journal of Health Communication, 14(5), 451–460. doi:10.1080/10810730903032978
   PubMed Web of Science ®Google Scholar
• Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., … Franks, P. (2005). Influence of patients’ requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293(16), 1995–2002. doi:10.1001/jama.293.16.1995
   PubMed Web of Science ®Google Scholar
• Krezmien, E., Wanzer, M. B., Servoss, T., & LaBelle, S. (2011). The role of direct-to-consumer pharmaceutical advertisements and individual differences in getting people to talk to physicians. Journal of Health Communication, 16(8), 831–848. doi:10.1080/10810730.2011.561909
   PubMed Web of Science ®Google Scholar
• Lee, B., Salmon, C. T., & Paek, H.-J. (2007). The effects of information sources on consumer reactions to direct-to-consumer (DTC) prescription drug advertising: A consumer socialization approach. Journal of Advertising, 36(1), 107–119. doi:10.2753/joa0091-3367360108
   Web of Science ®Google Scholar
• Lee, D., & Begley, C. E. (2010). Racial and ethnic disparities in response to direct-to-consumer advertising. American Journal of Health-System Pharmacy, 67(14), 1185–1190. doi:10.2146/ajhp090600
   PubMed Web of Science ®Google Scholar
• Lipsky, M. S., & Taylor, C. A. (1997). The opinions and experiences of family physicians regarding direct-to-consumer advertising. Journal of Family Practice, 45(6), 495–499.
   PubMed Web of Science ®Google Scholar
• McCaffrey, K. (2017). Drugmakers again boost DTC spending, to $5.6 billion in 2016. Retrieved from http://www.mmm-online.com/commercial/drugmakers-again-boost-dtc-spending-to-56-billion-in-2016/article/642028/
   Google Scholar
• Mintzes, B. (2012). Advertising of prescription-only medicines to the public: Does evidence of benefit counterbalance harm? Annual Review of Public Health, 33, 259–277. doi:10.1146/annurev-publhealth-031811-124540
   PubMed Web of Science ®Google Scholar
• Mintzes, B., Barer, M. L., Kravitz, R. L., Bassett, K., Lexchin, J., Kazanjian, A., … Marion, S. A. (2003). How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Association Journal, 169(5), 405–412.
   PubMed Web of Science ®Google Scholar
• Murray, E., Lo, B., Pollack, L., Donelan, K., & Lee, K. (2004). Direct-to-consumer advertising: Public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. Journal of the American Board of Family Practice, 17(1), 6–18.
   PubMedGoogle Scholar
• The Nielsen Company. (2016). The Nielsen total audience report: Q1 2016. The Nielsen Total Audience Series. Retrieved from http://www.nielsen.com/content/dam/corporate/us/en/reports-downloads/2016-reports/total-audience-report-q1-2016.pdf
   Google Scholar
• Parnes, B., Smith, P. C., Gilroy, C., Quintela, J., Emsermann, C. B., Dickinson, L. M., & Westfall, J. M. (2009). Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary care: A SNOCAP report. Annals of Family Medicine, 7(1), 41–46. doi:10.1370/afm.870
   PubMed Web of Science ®Google Scholar
• Paul, D. P., Handlin, A., & Stanton, A. D. (2002). Primary care physicians’ attitudes toward direct-to-consumer advertising of prescription drugs: Still crazy after all these years. Journal of Consumer Marketing, 19(7), 564–574. doi:10.1108/07363760210451393
   Google Scholar
• Robinson, A. R., Hohmann, K. B., Rifkin, J. I., Topp, D., Gilroy, C. M., Pickard, J. A., & Anderson, R. J. (2004). Direct-to-consumer pharmaceutical advertising: Physician and public opinion and potential effects on the physician-patient relationship. Archives of Internal Medicine, 164(4), 427–432. doi:10.1001/archinte.164.4.427
   PubMed Web of Science ®Google Scholar
• Selby, J. V., Beal, A. C., & Frank, L. (2012). The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. Journal of the American Medical Association, 307(15), 1583–1584. doi:10.1001/jama.2012.500
   PubMed Web of Science ®Google Scholar
• Singh, T., & Smith, D. (2005). Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing, 22(7), 369–378. doi:10.1108/07363760510631101
   Google Scholar
• Spake, D. F., & Joseph, M. (2007). Consumer opinion and effectiveness of direct-to-consumer advertising. Journal of Consumer Marketing, 24(5), 283–292. doi:10.1108/07363760710773102
   Google Scholar
• Spake, D. F., Joseph, M., & Megehee, C. M. (2014). Do perceptions of direct-to-consumer pharmaceutical advertising vary based on urban versus rural living?. Health Marketing Quarterly, 31(1), 31–45. doi:10.1080/07359683.2013.847344
   PubMedGoogle Scholar
• Sumpradit, N., Fors, S. W., & McCormick, L. (2002). Consumers’ attitudes and behavior toward prescription drug advertising. American Journal of Health Behavior, 26(1), 68–75. doi:10.5993/ajhb.26.1.7
   PubMed Web of Science ®Google Scholar
• Tentler, A., Silberman, J., Paterniti, D. A., Kravitz, R. L., & Epstein, R. M. (2008). Factors affecting physicians’ responses to patients’ requests for antidepressants: Focus group study. Journal of General Internal Medicine, 23(1), 51–57. doi:10.1007/s11606-007-0441-8
   PubMed Web of Science ®Google Scholar
• Viale, P. H., & Sanchez Yamamoto, D. (2004). The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications. Oncology Nursing Forum, 31(4), 777–783. doi:10.1188/04.ONF.777-783
   PubMed Web of Science ®Google Scholar
• Weissman, J. S., Blumenthal, D., Silk, A. J., Newman, M., Zapert, K., Leitman, R., & Feibelmann, S. (2004). Physicians report on patient encounters involving direct-to-consumer advertising. Health Affairs, Suppl Web Exclusives. W4-219-233. doi: 10.1377/hlthaff.w4.219
   Google Scholar
• Weissman, J. S., Blumenthal, D., Silk, A. J., Zapert, K., Newman, M., & Leitman, R. (2003). Consumers’ reports on the health effects of direct-to-consumer drug advertising. Health Affairs, Suppl Web Exclusives, W3, 82-95.
   Google Scholar